These two factors may explain the improved metabolic profiles observed in EV mice—particularly the decreased hepatic steatosis and plasma TG levels, which may increase insulin sensitivity, thereby alleviating glucose intolerance. This evidence concerns the gene INS and Hepatic steatosis.